Lista de obras - Alejo Chorny - Dominio Público Uruguay

A gut triumvirate rules homeostasis

artículo científico publicado en 2011

Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells.

artículo científico publicado en 2007

B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

artículo científico publicado en 2011

Bacterial DNA activates human neutrophils by a CpG‐independent pathway ⬇️

artículo científico publicado el 1 de noviembre de 2003

CEACAM1-S: The Virtues of Alternative Splicing in Gut Immunity ⬇️

artículo científico publicado el 16 de noviembre de 2012

Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia.

artículo científico publicado en 2006

Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

artículo científico publicado en 2006

Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria

artículo científico publicado en 2008

Gut T cell-independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells

artículo científico publicado en 2020

Immunoglobulin responses at the mucosal interface.

artículo científico publicado en 2011

Innate signaling networks in mucosal IgA class switching

artículo científico publicado en 2010

Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses

artículo científico publicado en 2015

Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1.

artículo científico publicado en 2008

Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation

artículo científico publicado en 2006

Regulation of frontline antibody responses by innate immune signals

artículo científico publicado en 2012

Regulation of immune tolerance by anti-inflammatory neuropeptides

artículo científico publicado en 2007

SORT1 Mutation Resulting in Sortilin Deficiency and p75(NTR) Upregulation in a Family With Essential Tremor.

artículo científico publicado en 2015

Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.

artículo científico publicado en 2006

The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells

artículo científico publicado en 2016

Therapeutic action of ghrelin in a mouse model of colitis.

artículo científico publicado en 2006

Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses.

artículo científico publicado en 2006

Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells

artículo científico publicado en 2007

Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses

artículo científico publicado en 2006

Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.

artículo científico publicado en 2007

Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders

artículo científico publicado en 2007

Tuning inflammation with anti-inflammatory neuropeptides

artículo científico publicado en 2007

VIP prevents experimental multiple sclerosis by downregulating both inflammatory and autoimmune components of the disease

scientific article published on 01 July 2006

VIP: an agent with license to kill infective parasites

artículo científico publicado en 2006

Vasoactive intestinal peptide family as a therapeutic target for Parkinson's disease.

artículo científico publicado en 2005

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

scientific article published on 04 October 2005

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation

artículo científico publicado en 2006

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

artículo científico publicado en 2006

Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.

artículo científico publicado en 2006

Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis

artículo científico publicado en 2006

Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response

artículo científico publicado en 2006

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

artículo científico publicado en 2005

Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation.

artículo científico publicado en 2006

Lista de obras de Alejo Chorny

A gut triumvirate rules homeostasis

Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells.

B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

Bacterial DNA activates human neutrophils by a CpG‐independent pathway ⬇️

CEACAM1-S: The Virtues of Alternative Splicing in Gut Immunity ⬇️

Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia.

Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria

Gut T cell-independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells

Immunoglobulin responses at the mucosal interface.

Innate signaling networks in mucosal IgA class switching

Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses

Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1.

Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation

Regulation of frontline antibody responses by innate immune signals

Regulation of immune tolerance by anti-inflammatory neuropeptides

SORT1 Mutation Resulting in Sortilin Deficiency and p75(NTR) Upregulation in a Family With Essential Tremor.

Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.

The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells

Therapeutic action of ghrelin in a mouse model of colitis.

Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses.

Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells

Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses

Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.

Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders

Tuning inflammation with anti-inflammatory neuropeptides

VIP prevents experimental multiple sclerosis by downregulating both inflammatory and autoimmune components of the disease

VIP: an agent with license to kill infective parasites

Vasoactive intestinal peptide family as a therapeutic target for Parkinson's disease.

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.

Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis

Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation.